KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilent Technologies (A) Cash & Equivalents (2016 - 2026)

Agilent Technologies (A) has disclosed Cash & Equivalents for 18 consecutive years, with $1.8 billion as the latest value for Q1 2026.

  • On a quarterly basis, Cash & Equivalents rose 19.84% to $1.8 billion in Q1 2026 year-over-year; TTM through Jan 2026 was $1.8 billion, a 19.84% increase, with the full-year FY2025 number at $1.8 billion, up 34.61% from a year prior.
  • Cash & Equivalents was $1.8 billion for Q1 2026 at Agilent Technologies, down from $1.8 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.8 billion in Q4 2025 to a low of $1.1 billion in Q4 2022.
  • A 5-year average of $1.4 billion and a median of $1.5 billion in 2025 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: decreased 29.04% in 2022, then skyrocketed 51.0% in 2023.
  • Agilent Technologies' Cash & Equivalents stood at $1.1 billion in 2022, then soared by 51.0% to $1.6 billion in 2023, then decreased by 16.42% to $1.3 billion in 2024, then surged by 34.61% to $1.8 billion in 2025, then decreased by 1.73% to $1.8 billion in 2026.
  • Per Business Quant, the three most recent readings for A's Cash & Equivalents are $1.8 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.5 billion (Q3 2025).